Variant report
Variant | nsv609988 |
---|---|
Chromosome Location | chr8:6104420-6108034 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:6106618..6108795-chr8:6113891..6116770,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000253880 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs551708197 | chr8:6104423-6104424 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs565129386 | chr8:6104452-6104453 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs531072554 | chr8:6104484-6104485 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs17465994 | chr8:6104491-6104492 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs147247743 | chr8:6104495-6104496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs536419684 | chr8:6104519-6104520 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs117183827 | chr8:6104533-6104534 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs116299063 | chr8:6104535-6104536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs538961583 | chr8:6104548-6104549 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs557776286 | chr8:6104552-6104553 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs541941766 | chr8:6104602-6104603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs6559126 | chr8:6104612-6104613 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
13 | rs537178816 | chr8:6104637-6104638 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs6559127 | chr8:6104638-6104639 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
15 | rs573899028 | chr8:6104645-6104646 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs542806405 | chr8:6104650-6104651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs183420933 | chr8:6104662-6104663 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs114711133 | chr8:6104670-6104671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs544962804 | chr8:6104680-6104681 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs79710017 | chr8:6104689-6104690 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs544507662 | chr8:6104691-6104692 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs530788177 | chr8:6104703-6104704 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs140753719 | chr8:6104704-6104705 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs144513236 | chr8:6104707-6104708 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs546740565 | chr8:6104709-6104710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs566943444 | chr8:6104710-6104711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs539355138 | chr8:6104718-6104719 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs4997125 | chr8:6104733-6104734 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs147438407 | chr8:6104762-6104763 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs537012468 | chr8:6104767-6104768 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs74580970 | chr8:6104768-6104769 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs573733972 | chr8:6104780-6104781 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs4997126 | chr8:6104781-6104782 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
34 | rs188465265 | chr8:6104805-6104806 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs139138050 | chr8:6104835-6104836 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs575224575 | chr8:6104853-6104854 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs4997127 | chr8:6104854-6104855 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
38 | rs558541358 | chr8:6104864-6104865 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs73522004 | chr8:6104875-6104876 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs544158438 | chr8:6104877-6104878 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs4997128 | chr8:6104902-6104903 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs529848399 | chr8:6104915-6104916 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs190526432 | chr8:6104952-6104953 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs149934420 | chr8:6104953-6104954 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs111572011 | chr8:6104961-6104962 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs183107192 | chr8:6104969-6104970 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs13273029 | chr8:6104977-6104978 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs78236303 | chr8:6104989-6104990 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs149059506 | chr8:6104993-6104994 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs567259541 | chr8:6105022-6105023 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Breast cancer | 21364760 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:6104000-6105600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
2 | chr8:6104000-6106000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
3 | chr8:6104400-6107400 | Enhancers | Primary hematopoietic stem cells | blood |
4 | chr8:6104800-6105200 | Enhancers | H1 Cell Line | embryonic stem cell |
5 | chr8:6105000-6107400 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
6 | chr8:6105200-6105600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
7 | chr8:6105600-6106400 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
8 | chr8:6106000-6106400 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
9 | chr8:6106400-6111200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
10 | chr8:6106400-6111200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
11 | chr8:6107000-6107200 | Enhancers | H1 Cell Line | embryonic stem cell |
12 | chr8:6107400-6110200 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
13 | chr8:6107400-6110600 | Weak transcription | Primary hematopoietic stem cells | blood |